Clinical Ink's eSouce Platform Selected to Power Global Central Nervous System Study

Clinical Ink's SureSource(R) Platform Will Provide Real-Time Data Capture and Remote Monitoring for Phase II Alzheimer's Clinical Trial

Clinical Ink's eSouce Platform Selected to Power Global Central Nervous System Study